id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-1445-0013,FDA,FDA-2013-D-1445,"Blood Glucose Monitoring Test Systems for Prescription Point-of-Care
Use; Draft Guidance for Industry and Food and Drug Administration Staff;
Extension of Comment Period",Notice,Extension of Comment Period,2014-04-09T04:00:00Z,2014,4,2014-04-09T04:00:00Z,2014-05-08T03:59:59Z,2014-05-09T01:02:01Z,2014-07898,0,0,09000064816ab265
FDA-2013-D-1445-0012,FDA,FDA-2013-D-1445,"Blood Glucose Monitoring Test Systems for Prescription Point-of-Care
Use; Draft Guidance for Industry and Food and Drug Administration Staff;
Extension of Comment Period",Notice,,2014-04-09T00:00:00Z,2014,4,,,2014-04-09T15:35:53Z,,0,1,09000064816ab3db
FDA-2013-D-1445-0002,FDA,FDA-2013-D-1445,"Blood Glucose Monitoring Test Systems for Prescription Point-of-Care
Use; Draft Guidance for Industry and Food and Drug Administration Staff",Other,Guidance,2014-01-08T05:00:00Z,2014,1,2014-01-08T05:00:00Z,,2024-11-07T23:01:39Z,,1,0,09000064814f47d7
FDA-2013-D-1445-0001,FDA,FDA-2013-D-1445,"Blood Glucose Monitoring Test Systems for Prescription Point-of-Care
Use; Draft Guidance for Industry and Food and Drug Administration Staff;
Availability",Notice,Notice of Availability,2014-01-07T05:00:00Z,2014,1,2014-01-07T05:00:00Z,2014-04-08T03:59:59Z,2014-07-01T17:05:55Z,2014-00023,0,0,09000064814f130a